# Advisor Review - Gemini-3-Flash

**Role:** Academic advisor checking for fatal errors
**Model:** gemini-3-flash-preview (ai_studio)
**Paper:** paper.pdf
**Timestamp:** 2026-02-26T15:17:28.017239
**Route:** Direct Google API + PDF
**Paper Hash:** 07e9bb7b71685a90
**Tokens:** 17278 in / 733 out
**Response SHA256:** de8eea623516ceae

---

I have reviewed the draft paper "Across the Channel: Social Networks and the Cross-Border Economic Effects of Brexit" for fatal errors. Please find my assessment below.

### 1. DATA-DESIGN ALIGNMENT
*   **Treatment Timing vs Data Coverage:** The paper defines the treatment as the June 2016 Brexit referendum. The outcome data (DVF) is stated to cover 2014 Q1 through 2023 Q4 (page 7). The treatment occurs well within the data coverage.
*   **Post-treatment Observations:** There are ample post-treatment observations (2016–2023).
*   **RDD/Cutoff:** Not applicable (continuous DiD).

### 2. REGRESSION SANITY
*   **Standard Errors:** Across all tables (Table 2, 3, 4, 5, 6, 8, 9, 10), standard errors are within a normal range (0.004 to 0.1) for log outcomes.
*   **Coefficients:** Most coefficients range from 0.003 to 0.15. The exchange rate coefficients in Table 4 are larger (~0.29) but consistent with the scale of exchange rate fluctuations. No coefficients exceed the fatal threshold (>10 for log, >100 for levels).
*   **Impossible Values:** $R^2$ values are positive and less than 1. No "NA" or "Inf" values are present in the results.

### 3. COMPLETENESS
*   **Placeholder Values:** I found no instances of "TBD", "PLACEHOLDER", or "XXX".
*   **Missing Required Elements:**
    *   Sample sizes ($N$) are clearly reported in the "Observations" row of every regression table.
    *   Standard errors are reported in parentheses.
    *   All figures and tables referenced in the text exist in the draft.
*   **Incomplete Analysis:** The paper mentions a German placebo (Section 6.2) and Swiss franc placebo (Section 6.1), both of which are reported in Table 2 and Table 3.

### 4. INTERNAL CONSISTENCY
*   **Numbers Match:**
    *   Abstract cites $\beta = 0.025, p = 0.031$ for the baseline. This matches Table 2, Column 1 ($0.0250^{**}$ with SE $0.0114$, which corresponds to $p \approx 0.028$—close enough for rounding/manual calculation consistency).
    *   Abstract cites German placebo $\beta = 0.045, p = 0.008$. This matches Table 2, Column 4.
    *   Abstract cites baseline price level control $\beta = 0.003$. This matches Table 5, Column 3.
*   **Timing/Sample Consistency:** The observation count (3,523) is consistent across all main tables. Table 6 correctly shows a reduced N (1,853) for the 2014–2018 sub-period.
*   **Specification Consistency:** Fixed effects (département and quarter-year) are applied consistently across all tables.

### FATAL ERRORS FOUND:
NONE.

**ADVISOR VERDICT: PASS**